Last reviewed · How we verify
Placebo lidocaine patches — Competitive Intelligence Brief
marketed
Pain Management / Dermatology
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo lidocaine patches (Placebo lidocaine patches) — University of Rochester. Placebo lidocaine patches deliver no active pharmaceutical ingredient, serving as a control comparator in clinical trials to assess the true efficacy of active lidocaine therapy.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo lidocaine patches TARGET | Placebo lidocaine patches | University of Rochester | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo lidocaine patches CI watch — RSS
- Placebo lidocaine patches CI watch — Atom
- Placebo lidocaine patches CI watch — JSON
- Placebo lidocaine patches alone — RSS
Cite this brief
Drug Landscape (2026). Placebo lidocaine patches — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-lidocaine-patches. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab